
Danaher Corp
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com. © 2025 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2025-14761 SOURCE Beckman Coulter Diagnostics
Price sits at 26% of its 52-week range.
Current Price
$191.12
+0.17%GoodMoat Value
$93.20
51.2% overvaluedDanaher Corp (DHR) Stock Chart
DHR Interactive Stock Chart
Interactive stock chart for Danaher Corp (DHR) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $191.12. 52-week high: $241.52. 52-week low: $173.43. 50-day moving average: $205.52. 200-day moving average: $209.00.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for DHR. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Danaher Corp's investment potential.